BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 35640416)

  • 21. Alternative splicing of interleukin-33 and type 2 inflammation in asthma.
    Gordon ED; Simpson LJ; Rios CL; Ringel L; Lachowicz-Scroggins ME; Peters MC; Wesolowska-Andersen A; Gonzalez JR; MacLeod HJ; Christian LS; Yuan S; Barry L; Woodruff PG; Ansel KM; Nocka K; Seibold MA; Fahy JV
    Proc Natl Acad Sci U S A; 2016 Aug; 113(31):8765-70. PubMed ID: 27432971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-33/ST2 Axis in Organ Fibrosis.
    Kotsiou OS; Gourgoulianis KI; Zarogiannis SG
    Front Immunol; 2018; 9():2432. PubMed ID: 30405626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-33 Alarmin and Its Active Proinflammatory Fragments Are Released in Small Intestine in Celiac Disease.
    Perez F; Ruera CN; Miculan E; Carasi P; Dubois-Camacho K; Garbi L; Guzman L; Hermoso MA; Chirdo FG
    Front Immunol; 2020; 11():581445. PubMed ID: 33133101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interleukin-33: from biology to potential treatments].
    Schmitt P; Girard JP; Cayrol C
    Med Sci (Paris); 2019 May; 35(5):440-451. PubMed ID: 31115327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells.
    Smithgall MD; Comeau MR; Yoon BR; Kaufman D; Armitage R; Smith DE
    Int Immunol; 2008 Aug; 20(8):1019-30. PubMed ID: 18550585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epithelial cell alarmin cytokines: Frontline mediators of the asthma inflammatory response.
    Duchesne M; Okoye I; Lacy P
    Front Immunol; 2022; 13():975914. PubMed ID: 36311787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detrimental role of IL-33/ST2 pathway sustaining a chronic eosinophil-dependent Th2 inflammatory response, tissue damage and parasite burden during Toxocara canis infection in mice.
    Leal-Silva T; Vieira-Santos F; Oliveira FMS; Padrão LLS; Kraemer L; da Paixão Matias PH; de Almeida Lopes C; Loiola Ruas AC; de Azevedo IC; Nogueira DS; Rachid MA; Caliari MV; Castro Russo R; Fujiwara RT; Bueno LL
    PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009639. PubMed ID: 34324507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pollen/TLR4 Innate Immunity Signaling Initiates IL-33/ST2/Th2 Pathways in Allergic Inflammation.
    Li J; Zhang L; Chen X; Chen D; Hua X; Bian F; Deng R; Lu F; Li Z; Pflugfelder SC; Li DQ
    Sci Rep; 2016 Oct; 6():36150. PubMed ID: 27796360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging Roles of IL-33/ST2 Axis in Renal Diseases.
    Chen WY; Li LC; Yang JL
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction.
    Barlow JL; Peel S; Fox J; Panova V; Hardman CS; Camelo A; Bucks C; Wu X; Kane CM; Neill DR; Flynn RJ; Sayers I; Hall IP; McKenzie AN
    J Allergy Clin Immunol; 2013 Oct; 132(4):933-41. PubMed ID: 23810766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The IL-33/ST2 axis is crucial in type 2 airway responses induced by Staphylococcus aureus-derived serine protease-like protein D.
    Teufelberger AR; Nordengrün M; Braun H; Maes T; De Grove K; Holtappels G; O'Brien C; Provoost S; Hammad H; Gonçalves A; Beyaert R; Declercq W; Vandenabeele P; Krysko DV; Bröker BM; Bachert C; Krysko O
    J Allergy Clin Immunol; 2018 Feb; 141(2):549-559.e7. PubMed ID: 28532656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Group 2 innate lymphoid cells (ILC2s) are important in typical type 2 immune-mediated diseases and an essential therapeutic target.
    Jin J; Sunusi S; Lu H
    J Int Med Res; 2022 Jan; 50(1):3000605211053156. PubMed ID: 35048721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung-resident CD69
    Kobayashi T; Iijima K; Matsumoto K; Lama JK; Kita H
    J Allergy Clin Immunol; 2023 Jul; 152(1):167-181.e6. PubMed ID: 36720287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-33 links tissue cells, dendritic cells and Th2 cell development in a mouse model of asthma.
    Eiwegger T; Akdis CA
    Eur J Immunol; 2011 Jun; 41(6):1535-8. PubMed ID: 21618506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy.
    Cayrol C; Girard JP
    Curr Opin Immunol; 2014 Dec; 31():31-7. PubMed ID: 25278425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ST2 requires Th2-, but not Th17-, type airway inflammation in epicutaneously antigen- sensitized mice.
    Morita H; Arae K; Ohno T; Kajiwara N; Oboki K; Matsuda A; Suto H; Okumura K; Sudo K; Takahashi T; Matsumoto K; Nakae S
    Allergol Int; 2012 Jun; 61(2):265-73. PubMed ID: 22361513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osthole attenuates ovalbumin‑induced lung inflammation via the inhibition of IL‑33/ST2 signaling in asthmatic mice.
    Yang Q; Kong L; Huang W; Mohammadtursun N; Li X; Wang G; Wang L
    Int J Mol Med; 2020 Oct; 46(4):1389-1398. PubMed ID: 32700747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune Cell-Epithelial/Mesenchymal Interaction Contributing to Allergic Airway Inflammation Associated Pathology.
    Hirahara K; Shinoda K; Morimoto Y; Kiuchi M; Aoki A; Kumagai J; Kokubo K; Nakayama T
    Front Immunol; 2019; 10():570. PubMed ID: 30972065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel allergic asthma model demonstrates ST2-dependent dendritic cell targeting by cypress pollen.
    Gabriele L; Schiavoni G; Mattei F; Sanchez M; Sestili P; Butteroni C; Businaro R; Mirchandani A; Niedbala W; Liew FY; Afferni C
    J Allergy Clin Immunol; 2013 Sep; 132(3):686-695.e7. PubMed ID: 23608732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ST2 regulates allergic airway inflammation and T-cell polarization in epicutaneously sensitized mice.
    Savinko T; Karisola P; Lehtimäki S; Lappeteläinen AM; Haapakoski R; Wolff H; Lauerma A; Alenius H
    J Invest Dermatol; 2013 Nov; 133(11):2522-2529. PubMed ID: 23633023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.